Photo of Margaret K. Callahan, MD, PhD

Margaret K. Callahan, MD, PhD

Professor of Immunology and Medicine
Chief, Division of Hematology/Oncology
Medical Director, Clinical Trials Office
NPI Number:
1508098534
Academic Office Location:
Neag Comprehensive Cancer Center
UConn Health
263 Farmington Avenue
Farmington, CT 06030
Phone: 800-579-7822
Website(s):

Neag Comprehensive Cancer Center

Immunology Graduate Program

  • Looking for a Physician?

    This faculty member is also
    a practicing physician at UConn Health.

    Learn more >
Education
DegreeInstitutionMajor
BSUniversity of ConnecticutMolecular and Cellular Biology
MDUConn School of MedicineMedicine
PhDUConn HealthBiomedical Science

Post-Graduate Training
TrainingInstitutionSpecialty
ResidencyUniversity of California at San FranciscoInternal Medicine, Molecular Medicine Training Program
FellowshipMemorial Sloan Kettering Cancer CenterMedical Oncology

Awards
Name of Award/HonorAwarding Organization
Science Translational Medicine Associate Scientific AdvisorScience Translational Medicine
Oncology Travel Trainee AwardConquer Cancer Foundation
Clinical Scholars Research Award, 2011-2012Memorial Sloan-Kettering Cancer Center
Connecticut State Medical Society AwardConnecticut State Medical Society
Trainee Travel AwardAmerican Society for Clinical Investigation
Medical Scientist Training Program (MSTP) Trainee, 1999-2007National Institutes of Health
Biotechnology Department Undergraduate Research AwardUniversity of Connecticut
Dean's List (1994-1998)University of Connecticut
New England Scholar, (1994-1998)University of Connecticut
  • Advanced Melanoma
  • Cancer Immunotherapy
  • Checkpoint Blockade
  • Targeted Inhibitors
  • Novel Therapies
  • Biomarker Development
  • Clinical Trials

Margaret Callahan, chief of the division of Hematology and Oncology in the Neag Cancer Center, is a board-certified medical oncologist specializing in the use of immunotherapies to treat melanoma and other cancers. Her research focuses on understanding how immunotherapies work in patients with the goal of characterizing facets of the human immune system that help or hinder the anti-tumor activity of current and novel agents. 

Accepting Lab Rotation Students: Spring 2 Block 2025

Journal Articles

Reviews